Essais liés8clinical trials
VilleWashington D.C.localisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06059638

Ouvrir le site du centre

Essais cliniques associés

8
MoléculeIndication / populationPhaseNCTTitreStatut
Ribociclib Cancer Phase 3 NCT05827081 Adjuvant WIDER — Phase IIIb Study of Ribociclib + ET in Early Breast Cancer RECRUITING
Biopsy Procedure Cancer Phase 2/3 NCT04628767 Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer RECRUITING
Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated Hypertension Non applicable NCT06059638 BACKBEAT — BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT RECRUITING
Biospecimen Collection Cancer Phase 3 NCT04267848 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) RECRUITING
Remibrutinib (Blinded) Myasthénie Phase 3 NCT06744920 RELIEVE — A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis RECRUITING
Ofatumumab approved dose SEP Phase 3 NCT06869785 FILIOS — Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab ACTIVE_NOT_RECRUITING
Remibrutinib oral treatment SEP Phase 3 NCT06846281 Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. RECRUITING
Renal Denervation (Symplicity Spyral™) Hypertension Non applicable NCT05198674 SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN ACTIVE_NOT_RECRUITING